Liraglutide Exerts Antidiabetic Effect via PTP1B and PI3K/Akt2 Signaling Pathway in Skeletal Muscle of KKAy Mice
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Background. Liraglutide (a glucagon-like peptide 1 analog) was used for the treatment of type 2 diabetes (T2DM) which could produce glucose-dependent insulin secretion.Aim. The aim was to investigate whether liraglutide could improve myofibril and mitochondria injury in skeletal muscle and the mechanisms in diabetic KKAy mice.Method. We divided the male KKAy mice into 2 groups: liraglutide group (250 μ g/kg/day liraglutide subcutaneous injection) and model group; meanwhile, the male C57BL/6J mice were considered as the control. After 6 weeks, the ultrastructure of skeletal muscle was observed by electron microscope. The gene expressions of protein tyrosine phosphatase 1B (PTP1B), phosphatidylinositol 3-kinase (PI3K), and glucose transporter type 4 (GLUT4) were determined by real-time PCR. The protein levels of the above molecules and phospho-Akt2 (p-Akt2) were measured by Western blot.Results. Liraglutide significantly ameliorated the injury of mitochondria by increasing the number (+441%) and the area (+113%) of mitochondria and mitochondrial area/100 µ m 2(+396%) in skeletal muscle of KKAy mice. The results of real-time PCR and Western blot showed that liraglutide downregulated PTP1B while it upregulated PI3K and GLUT4 (P<0.01). The protein level of p-Akt2/Akt2 was also increased (P<0.01).Conclusion. These results revealed that liraglutide could improve myofibril and mitochondria injury in skeletal muscle against T2DM via PTP1B and PI3K/Akt2 signaling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They reported a significant increase in mitochondrial area (+113%) and number (+441%) in the liraglutide treated animals compared with the control group [38].”
From The Effects of Glucagon-Like Peptide-1 Receptor Agonists on Mitochondrial Function Within Skeletal Muscle: A Systematic Review (2025) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The emerging evidence suggests that GLP‐1 RAs increase mitochondrial area, number and morphology (i.e., reduces swelling).”
From The Effects of Glucagon-Like Peptide-1 Receptor Agonists on Mitochondrial Function Within Skeletal Muscle: A Systematic Review (2025) · cites this paper as [38]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The KKAy mouse model (a rodent model of T2DM) presented with disarranged, swollen mitochondria clusters which visually improved following the 6‐week liraglutide treatment.”
From The Effects of Glucagon-Like Peptide-1 Receptor Agonists on Mitochondrial Function Within Skeletal Muscle: A Systematic Review (2025) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lungkaphin, A., Arjinajarn, P., Pongchaidecha, A., Srimaroeng, C., Chatsudthipong, L., & Chatsudthipong, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096236 · Cited by 22
RetractedPrevalence of Diabetes among Men and Women in China
Yang, W., Lu, J., Weng, J., Jia, W., Ji, L., Xiao, J., Shan, Z., Liu, J., Tian, H., Ji, Q., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908292 · Cited by 3,031
Self-citationFunctions and Mechanisms of Redox Regulation of Cysteine-Based Phosphatases
Salmeen, A., & Barford, D. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.560 · Cited by 312
Noyan-Ashraf, M. H., Shikatani, E. A., Schuiki, I., Mukovozov, I., Wu, J., Li, R.-K., Volchuk, A., Robinson, L. A., Billia, F., Drucker, D. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.091215 · Cited by 259 · cited 1×
“It has been known that liraglutide could reduce cardiac lipid accumulation [40].”
BackgroundMitochondrial Dysfunction and β-Cell Failure in Type 2 Diabetes Mellitus
Ma, Z. A., Zhao, Z., & Turk, J. (2012) · Experimental Diabetes Research · doi:10.1155/2012/703538 · Cited by 215
Effect of renal impairment on the pharmacokinetics of the GLP‐1 analogue liraglutide
Jacobsen, L. V., Hindsberger, C., Robson, R., & Zdravkovic, M. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03536.x · Cited by 215
Padiya, R., Chowdhury, D., Borkar, R. M., Srinivas, R., Bhadra, M. P., & Banerjee, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094228 · Cited by 142
Investigation of Protein-tyrosine Phosphatase 1B Function by Quantitative Proteomics
Mertins, P., Eberl, H. C., Renkawitz, J., Olsen, J. V., Tremblay, M. L., Mann, M., Ullrich, A., & Daub, H. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800196-mcp200 · Cited by 120
Osorio-Fuentealba, C., Contreras-Ferrat, A. E., Altamirano, F., Espinosa, A., Li, Q., Niu, W., Lavandero, S., Klip, A., & Jaimovich, E. (2013) · Diabetes · doi:10.2337/db12-1066 · Cited by 120
Inhibition of PTP1B Restores IRS1-Mediated Hepatic Insulin Signaling in IRS2-Deficient Mice
González‐Rodríguez, Á., Gutierrez, J. A. M., Sanz-Gonzalez, S. M., Ros, M., Burks, D. J., & Valverde, Á. M. (2009) · Diabetes · doi:10.2337/db09-0796 · Cited by 116
Research works printed but not linked: 5
- 2014, PLoS ONE, 9
- 2014, PLoS ONE, 9
- 2013, PLoS ONE, 8
- 2014, PLoS ONE, 9
- 2014, PLoS ONE, 9
Cited by
AKT in cancer: new molecular insights and advances in drug development
Mundi, P. S., Sachdev, J., McCourt, C., & Kalinsky, K. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13021 · Cited by 272
Old, V. J., Davies, M. J., Papamargaritis, D., Choudhary, P., & Watson, E. L. (2025) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.13677 · Cited by 55
Metadata
- Authors
- Ji, W., Chen, X., Lv, J., Wang, M., Ren, S., Yuan, B., Wang, B., & Chen, L.
- Affiliations
- Xi'an Jiaotong University (CN)
- First Hospital of Xi'an (CN)
- College of Medicine, Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China
- Corresponding author
- Chen, Lina
- Venue
- International Journal of Endocrinology
- Publisher
- Wiley
- Published
- 2014
- Volume
- 2014
- Pages
- 1-9
- ISSN
- 1687-8337 (ISSN-L)
- 1687-8345
- PMC
- PMC4144308
- OpenAlex
- W1993249979
- Cited by
- 36
- References
- 40
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 1 · 2022: 5 · 2021: 4 · 2020: 1 · 2019: 6 · 2017: 6 · 2016: 4 · 2015: 2
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- International Journal of Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Youth Foundation of China (30901808, 2011KTCL03-20)
- Technology and Innovation Project of Shaanxi Province (30901808, 2011KTCL03-20)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- liraglutide, type 2 diabetes, skeletal muscle, PTP1B, GLUT4, mitochondrial injury, KK-Ay mice, glucagon-like peptide-1 analogues
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Liraglutide Exerts Antidiabetic Effect via PTP1B and PI3K/Akt2 Signaling Pathway in Skeletal Muscle of KKAy Mice. https://app.cochat.ai/papers/10.1155/2014/312452
- The paper
- Ji, W., Chen, X., Lv, J., Wang, M., Ren, S., Yuan, B., Wang, B., & Chen, L. (2014). Liraglutide Exerts Antidiabetic Effect via PTP1B and PI3K/Akt2 Signaling Pathway in Skeletal Muscle of KKAy Mice. International Journal of Endocrinology. https://doi.org/10.1155/2014/312452
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.